Analyzing Healthcare

Roy Bejarano and Jason Schifman: SCALE Community and SCALE Healthcare
  • 5.0 (1)
  • BUSINESS
  • UPDATED SEMIWEEKLY

What’s next in healthcare? Analyzing Healthcare delivers expert insights, real-world case studies, and bold ideas shaping the future of U.S. & global health systems. Hosted by Roy Bejarano and Jason Schifman of SCALE Healthcare & SCALE Community, each episode explores medical innovation, healthcare leadership, value-based care, provider operations, health policy, artificial intelligence, & emerging health trends. Whether you're a provider, investor, operator, or simply healthcare curious—this podcast helps you stay informed, inspired, & ahead of the curve. More info at www.scale-community.com

  1. 4D AGO

    Inside a 51-Hospital System's Agentic AI Playbook | Mark Townsend, Chief Clinical Digital Ventures Officer, BSMH

    In this episode, Roy Bejarano talks to Mark Townsend, Chief Clinical Digital Ventures Officer at Bon Secours Mercy Health, about digital transformation. Mark discusses how Acrete Health Partners drives operator-led solutions, successful tech adoption, and examples like agentic AI and nursing ambient documentation. They also cover AI risk, EHR limits, and distinguishing true innovation from trends.What You’ll Learn How Bon Secours Mercy Health structures its venture and digital innovation strategyWhy BSMH shifted from investing in “solutions seeking problems” to operator-led problem-solvingWhy Mark measures digital success through one word: profitabilityWhy health systems should frame initiatives as projects, not pilotsHow executive accountability and P&L ownership improve implementation successWhat “grow your way to success” means in a health system contextHow BSMH evaluates Epic vs. third-party AI solutionsWhy omnichannel appointment scheduling became a key system-level AI use caseHow nursing ambient documentation differs from physician ambient toolsWhy governance, human oversight, and informed consent matter in AI adoptionKey Timestamps (00:00) – Introduction to Mark Townsend and Bon Secours Mercy Health(00:52) – Mark’s journey from congenital cardiology to digital ventures(03:35) – Inside BSMH’s venture model and Acrete Health Partners(06:21) – Why BSMH now focuses on operator-led problem statements(10:55) – The real rules of technology adoption in health systems(12:16) – Why Mark rejects the word “pilot”(13:44) – Accountability, operational ownership, and project champions(14:44) – The acceleration fund and matching operator investment(16:52) – “Grow your way to success” and run-rate improvement(18:23) – Fail fast, fail forward, and design for scale(20:12) – Agentic AI for appointment scheduling: success and failure in one story(23:39) – Epic, MyChart, and why the EHR cannot be all things to all people(26:42) – Co-development, Brado, and the “big smelly onion” of implementation(28:47) – Nursing ambient documentation with Epic and Abridge(30:47) – AI governance, human-in-the-loop, and risk mitigation(32:39) – Using AI for quality and compliance at scaleKey Takeaways Health system innovation works best when operators bring the problem, not vendorsStrategic investing loses credibility if the health system never uses what it fundsIn Mark’s framework, margin is the mission—profitability is the baseline test“Project” signals commitment; “pilot” signals optionality and weak accountabilityExecutive sponsorship matters more than enthusiasm from the technology vendorThe best digital initiatives are tied to strategic priorities and measurable scaleEpic remains central, but third-party tools still fill critical workflow gapsHealthcare AI adoption requires governance, informed risk acceptance, and humans in the loopClinical AI use cases are moving beyond physicians to nurses and broader care teamsReal implementation is messy, bespoke, and deeply dependent on operational readinessResource Links Guest: Mark Townsend – Chief Clinical Digital Ventures Officer, Bon Secours Mercy HealthHost: Roy Bejarano – CEO & Co-Founder, SCALE HealthcarePodcast: Analyzing Healthcare by SCALE CommunitySCALE Community: SCALE Community WebsiteGuest BioMark Townsend is the Chief Clinical Digital Ventures Officer at Bon Secours Mercy Health, leading digital transformation at one of the largest U.S. health systems. With expertise in clinical practice, health system operations, and digital innovation, he focuses on scaling practical, ROI-driven solutions across the organization. SEO KeywordsHealthcare AI, Digital Health, Health System Innovation, Bon Secours Mercy Health, BSMH, Mark Townsend, Roy Bejarano, Healthcare Ventures, Epic, MyChart, Ambient Documentation, Nursing AI, Agentic AI, Appointment Scheduling, Healthcare ROI, Digital Transformation, Health System Strategy, Healthcare Operations, Clinical Innovation

    44 min

  2. APR 1

    Is the Medicare Advantage Business Model Fundamentally Broken? Sachin H. Jain, CEO of SCAN Health Plan

    Medicare Advantage, value-based care, senior health, and healthcare ethics—Dr. Sachin Jain and Roy Bejarano unpack what sustainable healthcare reform should actually look like. In this episode of Analyzing Healthcare, Roy Bejarano speaks with Dr. Sachin Jain, CEO of SCAN Health Plan, the largest not-for-profit Medicare Advantage health plan in the U.S. They explore the current state of Medicare Advantage, what separates strong plans from weak ones, and why healthcare leadership must return to ethics, prevention, and long-term value creation. Sachin explains how SCAN scaled to roughly 440,000 members, why star ratings matter so much, and how delegated risk models can create better alignment between plans and providers. He also shares lessons from operating across payer and care delivery models, why vertical integration is harder than many assume, and how the future of senior care must move beyond paying for sickness toward keeping people healthy. What You’ll Learn  ✅ What most leaders misunderstand about Medicare Advantage ✅ The difference between “good” and “bad” MA models ✅ How risk adjustment and coding incentives distorted the market ✅ Why V28 exposed weaker MA operators ✅ How SCAN uses delegated risk and provider partnerships ✅ Why star ratings are critical for growth and economics ✅ Why building care delivery platforms is operationally difficult ✅ How ethics and incentives shape healthcare performance ✅ Why senior care must shift toward prevention and outcomes Key Timestamps (00:00) Introduction to Medicare Advantage and SCAN Health Plan (02:38) Challenges in Care Delivery and Scaling Services (05:31) Understanding Medicare Advantage: Good vs. Bad Plans (08:27) Federal Changes and Their Impact on Medicare Advantage (10:49) The Ethical Landscape of Healthcare (13:47) Growth and Expansion of SCAN Health Plan (16:26) Partnerships and Provider Relationships (18:59) Navigating the Medicare Advantage Market (21:41) Future of Senior Care and Healthcare System (24:35) Lessons from Previous Experiences in Healthcare (27:11) Conclusion and Future Outlook Key Takeaways  💎 Strong Medicare Advantage plans improve care coordination and outcomes 💎 Weak MA models rely too heavily on coding and short-term incentives 💎 SCAN’s growth has been driven by discipline, trust, and star performance 💎 Delegated risk works best when providers are aligned around outcomes 💎 Vertical integration is strategically valuable but hard to execute 💎 Healthcare needs stronger ethical leadership and better incentives 💎 The future of senior care is prevention, not reactive reimbursement Guest Bio Dr. Sachin H. Jain, MD, MBA, is CEO of SCAN Group and SCAN Health Plan, where he leads growth, diversification, and healthcare equity efforts. Under his leadership, SCAN has expanded into new markets, launched innovative health plan products, and earned leading quality and customer satisfaction ratings. Previously, he led CareMore Health and Aspire Health and held leadership roles at Merck and HHS. Dr. Jain is a physician, policy expert, board member, and nationally recognized thought leader in healthcare. SEO Keywords Healthcare, Medicare Advantage, Value-Based Care, Senior Care, SCAN Health Plan, Sachin Jain, Roy Bejarano, Scale Community, Healthcare Leadership, Risk Adjustment, V28, Delegated Risk, Star Ratings, Preventive Care, Population Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

    40 min

  3. MAR 18

    Orthopedic Scale Done Right: Independence, Alignment, and Long-Term Value Creation

    Orthopedic MSO strategy, hospital partnerships, physician independence, AI in healthcare, and Rothman Orthopaedics growth. In this episode of Analyzing Healthcare, Jason Schifman speaks with Christian Ellison, CEO of Rothman Orthopaedics, about building one of the nation’s leading doctor-owned orthopedic platforms. They discuss physician independence, hospital partnerships, ambulatory growth, patient access, AI-enabled care delivery, and why focused specialty platforms may outperform traditional employed models. Christian also shares Rothman’s approach to market expansion, recruiting, and scaling orthopedic care without losing strategic focus. What You’ll Learn✅ Why independent physician groups may outperform employed models✅ How Rothman partners with hospitals across Pennsylvania, New Jersey, and Florida✅ What “demand matching” means in orthopedic care delivery✅ How nurse navigation reduces friction and keeps patients out of the ER✅ Why AI should move beyond efficiency into care redesign✅ How Rothman scaled from 0% to 30% market share in Orlando in 3 years✅ Why physician training pipelines matter for growth✅ The role of brand in recruiting doctors across markets✅ What specialties are most likely to move from acute care to ambulatory settings✅ Why focus — not over-expansion — creates real value in specialty care Key Timestamps• (01:06) Rothman’s footprint and doctor-owned model• (02:45) How Rothman structures hospital partnerships• (07:13) Why integrated care is better for patients• (12:21) “Demand matching” and nurse navigation• (13:37) AI and the future of care delivery• (15:23) Why hospitals are more open to partnership now• (18:43) Independent groups vs. employed physician economics• (29:43) Florida expansion and 30% market share growth• (36:12) Rothman’s 3–5 year growth strategy• (46:41) “The reason we’re so good is because all we do is orthopedics. Key Takeaways• 💎 Organizations must focus on delivering specialized care to achieve excellence.• 💎 Comprehensiveness in care is challenging for hospital systems with multiple specialties.• 💎 Emerging organizations like Rothman Orthopedics are setting new standards in specialized care.• 💎 Collaboration between specialized organizations can create significant market value.• 💎 Quality care requires sophisticated systems and processes.• 💎 The healthcare market is evolving with a focus on specialized services.• 💎 Delivering the best care involves custom components tailored to specific needs.• 💎 Healthcare providers face challenges in maintaining excellence across various specialties.• 💎 The emergence of specialized organizations can lead to improved patient outcomes.• 💎 A focused approach in healthcare can drive innovation and efficiency. Resource LinksGuest: Christian Ellison – CEO, Rothman OrthopaedicsHost: Jason Schifman – President & Co-Founder, SCALE HealthcarePodcast: Analyzing Healthcare by SCALE CommunitySCALE Community: https://www.scale-community.comSCALE Healthcare: https://www.scale-healthcare.comRothman Orthopaedics: https://rothmanortho.com Guest Bio-Christian Ellison is CEO of Rothman Orthopaedics, the largest private musculoskeletal practice in the U.S. With more than 30 years of healthcare leadership experience, he is known for driving strategic growth, operational excellence, and multi-market expansion across physician-led organizations. His expertise includes scaling outpatient care delivery models, strengthening performance across complex healthcare platforms, and leading specialty care organizations through transformation. Prior to Rothman, he served as CEO and Board Member at EVP EyeCare, an investor-backed ophthalmic care organization. SEO KeywordsRothman Orthopaedics, Christian Ellison, Jason Schifman, SCALE Healthcare, Analyzing Healthcare, orthopedic MSO, hospital partnerships, physician independence, value-based care, ambulatory surgery centers, orthopedic strategy

    45 min

  4. MAR 4

    What Does It Take to Keep a 150-Year-Old Hospital Alive?- Dixie James, Regional President, Jefferson Health

    Health system mergers, safety-net sustainability, AI in healthcare, and FTC scrutiny—Dixie James and Roy Bejarano unpack what responsible scale really means.In this episode of Analyzing Healthcare, Roy Bejarano speaks with Dixie James,Regional President at Jefferson Health, about the realities of integrating health systems without losing mission or community trust. Drawing on her leadership through the Einstein Healthcare Network merger—including FTC opposition and COVID—Dixie explains why safety-net hospitals cannot survive without scale and capital access. She shares lessons from integration, AI investment, health plan performance, and why culture—not capital—is the hardest part of any merger. A candid discussion on regulation, regional strategy, and the human side of healthcare consolidation. What You’ll Learn ✅ Why safety-net hospitals are unsustainable without scale and capital access✅ What the FTC often misunderstands about hospital mergers✅ How regional scale improves coordinated care across the continuum✅ Why integration success depends more on people than process✅ Lessons learned from Einstein → Jefferson vs. Lehigh Valley integration✅ How large systems pilot AI, automation, and virtual nursing at scale✅ The strategic role of Jefferson’s health plan in population health✅ Why GLP-1 exposure disrupted payer economics in 2025✅ How regional concentration enables true “soup-to-nuts” care✅ Why change management can make or break a merger Key Timestamps • (00:00) Introduction to Dixie James and Jefferson’s scale• (03:24) The five-year merger journey: FTC challenge, AG opposition, and COVID• (06:20) Safety-net payer mix (85–90% government) and sustainability reality• (08:52) What Einstein’s culture brought to Jefferson• (13:26) If she could go back to 2015: technology investments and AI readiness• (14:35) Jefferson’s AI Center of Excellence and research infrastructure• (16:46) Observing other mergers: monopoly fears vs. mission-driven scale• (21:15) Coordinated vs. uncoordinated care—regional advantages• (23:36) Jefferson Health Plan performance and GLP-1 impact• (26:46) Lessons learned: Einstein integration vs. Lehigh Valley• (31:33) The hardest part of integration—“moving people’s cheese” Key Takeaways • 💎 Scale isn’t about monopoly—it’s about sustainability for safety-net care• 💎 85–90% government payer mix is financially unsustainable without capital access• 💎 Regional density enables coordinated, continuous care—not episodic treatment• 💎 AI investment requires infrastructure smaller systems can’t afford• 💎 Integration fails when teams don’t understand the “why”• 💎 Culture transfer from small systems can strengthen large enterprises• 💎 Health plans must align strategically with system population health goals• 💎 Change management—not finance—is the hardest integration challenge Resource Links Guest: Dixie James – Regional President, Jefferson HealthHost: Roy Bejarano – CEO & Co-Founder, SCALE HealthcarePodcast: Analyzing Healthcare by SCALE CommunitySCALE Community: https://www.scale-community.com Guest Bio Dixie Anne James is Regional President of Jefferson Hospital, overseeing a multi-hospital academic and community network across Pennsylvania and New Jersey. With more than 25 years in healthcare leadership, she previously served as President and CEO of Einstein Medical Center Philadelphia and played a key role in the merger of Einstein Healthcare Network with Jefferson. Her expertise spans safety-net sustainability, large-scale integration, service line growth, and advancing coordinated, technology-enabled care. SEO Keywords Healthcare, Mergers, Technology, Community Care, Leadership, Jefferson Health, Einstein Health, Regulatory Challenges, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

    35 min

  5. FEB 18

    How Hospital Clínic Barcelona Is Driving Europe’s Healthcare Innovation Engine - Jorge Fernandez

    Jorge Juan Fernandez discusses public healthcare innovation, hospital spinouts, CAR-T therapies, and why collaboration is shaping modern care delivery. In this episode of Analyzing Healthcare, he joins Jason Schifman to share how Hospital Clínic Barcelona became one of Europe’s most dynamic innovation engines.Fernandez explains how a public healthcare system can launch venture-backed startups, develop CAR-T therapies, and embed innovation across 9,000 employees. The discussion covers commercialization, operational ROI, cultural transformation, primary care integration, and hospital alliances that expand access and reduce inefficiencies. He emphasizes that innovation must improve operations—and that no single hospital can deliver world-class care alone. What You’ll Learn • ✅ How a public hospital created 30+ spinout companies across biotech, medtech, and digital health• ✅ The three-part innovation model: In-Out, In-In, and Out-In• ✅ Why operational improvement—not hype—is the test for adopting new technology• ✅ How frontline clinicians and nurses drive meaningful innovation• ✅ Why public systems can compete with pharma through structured tech transfer• ✅ How CAR-T therapies moved from research to national deployment• ✅ Why strategic partnerships are essential for modern healthcare delivery Key Timestamps • (00:43) Introduction to Hospital Clínic Barcelona and its global positioning• (09:43) Defining innovation in a public hospital system• (10:06) 30+ spinouts: competing with pharma and building companies• (15:35) Building a culture of innovation across 9,000 employees• (20:10) Internal innovation awards and frontline problem-solving• (26:56) Operational ROI: why great startups still fail in hospitals• (33:00) Strategic partnerships with primary care and rural hospitals• (36:40) “One hospital is not enough” — collaboration as strategy Key Takeaways • 💎 Public healthcare systems can innovate at scale with structured pathways• 💎 Commercial success begins with research strength and tech transfer discipline• 💎 Innovation must materially improve operations to earn adoption• 💎 Frontline pain points—not executive mandates—drive sustainable change• 💎 Strategic alliances expand access without duplicating infrastructure• 💎 Collaboration across care settings is a competitive advantage Guest Jorge Juan Fernandez GarciaChief Innovation Officer at Hospital Clínic Barcelona Guest Bio Jorge Juan Fernandez Garcia is Chief Innovation Officer at Hospital Clínic Barcelona, leading innovation strategy across four institutions within Campus Clínic Barcelona, including research foundations and global health initiatives. Under his leadership, the organization has launched more than 30 spinout companies across biotech, medtech, and digital health. Hospital Clínic is a top-ranked public tertiary hospital and a European leader in CAR-T therapy development, competing directly with pharmaceutical manufacturers in advanced therapies and translational research. Subscribe Subscribe to Analyzing Healthcare for candid conversations with healthcare leaders, clinicians, and system builders exploring healthcare strategy, AI in healthcare, digital health, and the future of care delivery. Visit Scale Community- www.scale-commmunity.com to access exclusive healthcare insights, member-only recordings, and leadership perspectives from across the global healthcare ecosystem. Keywords public healthcare innovation, Hospital Clínic Barcelona, Jorge Fernandez, healthcare innovation, CAR-T therapy, biotech startups, hospital spinouts, digital health, healthcare commercialization, healthcare strategy, public-private partnerships, healthcare cost efficiency, hospital alliances, primary care integration, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

    41 min

  6. FEB 11

    Physician Burnout, Private Equity, and AI: What Comes Next for U.S. Healthcare? with Kevin Pho, Founder at KevinMD

    Physician burnout, AI in healthcare, and private equity—Kevin Pho and Roy Bejarano explore the future of U.S. medicine and its challenges. In this episode of Analyzing Healthcare, host Roy Bejarano sits down with Kevin Pho, MD, founder of KevinMD, to examine what’s driving physician burnout—and what might actually help fix U.S. healthcare. Drawing on two decades as a practicing physician and leading voice in healthcare media, Kevin unpacks the loss of autonomy, growing corporatization, reimbursement pressure, and productivity metrics pushing clinicians toward burnout. He explains why burnout is a slow-burn crisis, how online platforms have replaced the physician lounge, and why isolation is worsening across specialties. The conversation also explores AI’s role in healthcare, separating tools that reduce cognitive load from those that introduce new clinical and ethical risks, alongside a candid discussion on private equity, regulation, and patient outcomes. What You’ll Learn Why physician burnout is worsening—even as healthcare spending rises. How loss of autonomy and corporatization are reshaping medical practice. Why productivity metrics and reimbursement pressures fuel moral injury. How KevinMD became a modern “physician lounge” for shared experience. Where AI genuinely helps clinicians—and where it creates new risks. Why ambient AI scribes may reduce burnout but raise privacy questions. How Silicon Valley’s pace clashes with patient safety realities. The unresolved debate around private equity and patient outcomes. Why training more physicians alone won’t fix access or burnout. What healthcare leaders must prioritize over the next decade. Key Timestamps (00:00) Kevin Pho’s journey from primary care physician to KevinMD(04:25) Burnout, moral injury, and why physicians feel isolated(07:45) Loss of autonomy and the corporatization of medicine(10:10) Are physicians burning out faster—or just steadily worse?(13:40) Metrics vs. medicine: where the system breaks(17:15) Private equity in healthcare—risk, reality, and regulation(24:35) AI in healthcare: real tools vs. dangerous hype(26:40) Why AI won’t replace doctors—but may replace those who ignore it(29:20) “Move fast and break things” vs patient safety(33:30) Residency caps, physician shortages, and structural bottlenecks Key Takeaways Burnout is a systemic failure, not an individual weakness. Loss of physician autonomy is a primary driver of moral injury. Metrics without clinical context worsen care and clinician wellbeing. AI can reduce cognitive load—but also introduce serious safety risks. Healthcare cannot adopt Silicon Valley’s speed without consequences. Private equity’s impact on care is nuanced—not binary. Training more doctors won’t solve access without structural reform. Resource Links Guest: Kevin Pho, MD – Founder, KevinMDHost: Roy Bejarano – CEO & Co-Founder, SCALE HealthcarePodcast: Analyzing HealthcareSCALE Community: https://www.scale-community.com Guest Bio Dr. Kevin Pho is a board-certified internal medicine physician and the founder of KevinMD, the leading physician-led media platform amplifying frontline clinical voices. Since launching KevinMD in 2004, he has built a global community where clinicians share real-world experiences on burnout, autonomy, health policy, and emerging technologies like AI. Dr. Pho brings a practicing physician’s perspective to national healthcare debates and continues to care for patients in New Hampshire. SEO Keywords Physician burnout, Kevin Pho, KevinMD, AI in healthcare, healthcare innovation, private equity in healthcare, physician autonomy, healthcare policy, healthcare AI, medical burnout, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Roy Bejarano, Jason Schifman

    38 min

  7. FEB 4

    Is AI the First Technology Doctors Actually Trust? Robert Wachter, Author & Chair of Medicine, UCSF

    Bob Wachter on AI in healthcare, EMRs, digital health, clinician burnout, and why generative AI may succeed where healthcare technology failed. In this episode of Analyzing Healthcare, Jason Schifman speaks with Bob Wachter, Chair of Medicine at UCSF and author of A Giant Leap, on why AI may finally transform healthcare. Wachter explains how EMRs increased administrative burden without delivering productivity gains, and why generative AI marks a shift by making clinical data and decision-making computable. The conversation covers real-world AI adoption—scribes, chart summarization, and decision support—while examining ROI, clinical risk, and human oversight. Wachter emphasizes that AI won’t fix healthcare’s incentives, but it can meaningfully improve clinician experience and care delivery. What You’ll Learn Why EMRs digitized healthcare without transforming it What makes generative AI fundamentally different from prior health IT waves Where AI delivers real value today—and where it still falls short Why clinician experience may be AI’s strongest early ROI How AI could reshape diagnosis, testing, and treatment decisions The risks of human–AI collaboration in clinical care Why AI can improve healthcare without replacing doctors Key Timestamps (00:00) Introduction to Bob Wachter and AI in healthcare (04:13) Why EMRs failed to transform healthcare delivery (09:37) General-purpose technology and healthcare digitization (15:42) Why AI adoption is happening “suddenly,” not gradually (19:38) What makes generative AI different from past tools (34:03) AI scribes: adoption, experience, and ROI reality (38:15) Clinical decision support as AI’s true “home run” (44:16) Unintended consequences and the human-in-the-loop risk Key Takeaways 💎 Digitization alone does not equal transformation 💎 Generative AI enables healthcare data to become computable 💎 Clinician experience is a critical early driver of AI adoption 💎 Real cost savings depend on changing clinical decisions, not documentation 💎 AI can improve healthcare without fixing broken incentives 💎 Human oversight introduces new risks alongside new benefits Guest Bob Wachter, MDChair, Department of Medicine, UCSFAuthor, A Giant Leap: How AI Is Transforming Healthcare and What It Means for Our Future Guest Bio Bob Wachter, MD, is Professor and Chair of the Department of Medicine at the University of California, San Francisco, and a nationally recognized leader in healthcare quality, safety, and innovation. He coined the term “hospitalist,” the fastest-growing medical specialty in U.S. history, and has authored six books and hundreds of articles on health technology and policy. His 2015 book The Digital Doctor was a New York Times bestseller, and his latest, A Giant Leap, explores AI’s impact on care. Subscribe Subscribe to Analyzing Healthcare for candid conversations with healthcare leaders, clinicians, and system builders exploring healthcare strategy, AI in healthcare, digital health, and the future of care delivery. Visit Scale Community- www.scale-commmunity.com to access exclusive healthcare insights, member-only recordings, and leadership perspectives from across the global healthcare ecosystem. Keywords AI in healthcare, Bob Wachter, healthcare innovation, electronic health records, EMR adoption, digital health, clinical decision support, physician, healthcare productivity, healthcare costs, healthcare technology, affordable healthcare, healthcare solutions, healthcare access, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

    46 min

  8. JAN 28

    Inside the Mind of a Global Biotech Investor: What Actually Gets Funded- Dr. George Syrmalis, CEO, Bioscience Equity Partners

    Healthcare innovation doesn’t fail because of a lack of science—it fails when governance, execution, and incentives break down. In this episode of Analyzing Healthcare, host Roy Bejarano, CEO & Co-Founder of SCALE Healthcare, sits down with George Syrmalis, Founder & CEO of Bioscience Equity Partners, to unpack how early-stage biotech, medtech, and digital health investments are really evaluated—and why most countries fail to attract global capital. Drawing on decades of experience as a physician, biotech founder, and global investor, George explains why governance, intellectual property, execution quality, and regulatory clarity matter more than geography. The conversation explores early-stage biotech funding, global clinical trial strategy, FDA vs international regulators, Big Pharma’s looming patent cliff, radiopharmaceuticals, AI in drug discovery, and why “innovation without impact” doesn’t get funded. From why the U.S. remains the most attractive biotech market to how Saudi Arabia is rapidly emerging as a future life sciences hub, this episode delivers a rare, operator-level view into how capital actually flows across global healthcare innovation. What You’ll Learn ✅ How global biotech investors assess early-stage risk and return✅ Why governance and IP matter more than geography✅ How FDA clarity often outweighs lower clinical trial costs abroad✅ Why many countries struggle to attract life sciences capital✅ The real bottlenecks in clinical trials and contract manufacturing✅ How Big Pharma’s patent cliff will reshape M&A and deal flow✅ Where radiopharmaceuticals, medtech, and AI are creating real value✅ Why most “AI in healthcare” pitches don’t survive diligence Key Timestamps • (00:00) George Syrmalis’ background and investment philosophy• (05:10) Governance, IP, and biotech deal breakers• (10:20) Why the U.S. dominates global biotech investing• (12:15) Where to run clinical trials—and where not to• (18:20) FDA clarity vs lower-cost regulators• (22:35) Big Pharma’s patent cliff and M&A surge• (25:30) Where capital is moving in biotech and medtech• (29:40) Real AI vs hype in healthcare• (32:00) Tariffs, pricing risk, and capital strategy Key Takeaways • 💎 Early-stage biotech success depends on execution, governance, and IP• 💎 FDA transparency often outweighs lower global trial costs• 💎 Clinical trial quality matters more than geography• 💎 Manufacturing failures can derail approvals and destroy value• 💎 Big Pharma’s patent cliff will drive aggressive M&A• 💎 Radiopharmaceuticals and medtech are entering a second growth wave• 💎 Most healthcare AI pitches fail real diligence Resource Links Guest: George Syrmalis – Founder & CEO, Bioscience Equity PartnersHost: Roy Bejarano – Analyzing HealthcareCommunity: www.scale-community.comPodcast Hub: Analyzing Healthcare by SCALE Community Guest Bio Dr. George Syrmalis is a physician-scientist, entrepreneur, and global healthcare investor best known as Founder & CEO of Bioscience Equity Partners, a specialist investment bank and fund manager focused on early-stage biotech, med-tech, and digital health ventures. He has decades of experience bridging scientific innovation and capital markets, helping groundbreaking life sciences technologies advance from discovery through financing and public markets. His leadership emphasizes rigorous science, governance, and strategic execution to accelerate meaningful healthcare innovations worldwide. SEO Keywords Biotech, healthcare investment, clinical trials, AI in healthcare, Dr. George Syrmalis, investment strategies, global healthcare, pharmaceutical industry, innovation in medicine, biotech trends, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Roy Bejarano, Scale Community, Jason Schifman

    34 min
See All (106)

Ratings & Reviews

About

What’s next in healthcare? Analyzing Healthcare delivers expert insights, real-world case studies, and bold ideas shaping the future of U.S. & global health systems. Hosted by Roy Bejarano and Jason Schifman of SCALE Healthcare & SCALE Community, each episode explores medical innovation, healthcare leadership, value-based care, provider operations, health policy, artificial intelligence, & emerging health trends. Whether you're a provider, investor, operator, or simply healthcare curious—this podcast helps you stay informed, inspired, & ahead of the curve. More info at www.scale-community.com

Information

  • Creator
    Roy Bejarano and Jason Schifman: SCALE Community and SCALE Healthcare
  • Years Active
    2024 - 2026
  • Episodes
    106
  • Rating
    Clean
  • Copyright
    © Roy Bejarano and Jason Schifman: SCALE Community and SCALE Healthcare
  • Show Website
    Analyzing Healthcare

You Might Also Like